Wolverine Trading
FOLD

Wolverine Trading’s Amicus Therapeutics FOLD Stock Holding History

Wolverine Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$90.5K Sell
11,399
-15,039
-57% -$107K ﹤0.01% 5231
2025
Q2 		$157K Sell
26,438
-9,712
-27% -$62.7K ﹤0.01% 4025
2025
Q1 		$305K Buy
+36,150
New +$335K ﹤0.01% 3507
2024
Q4 		– Sell
-59,772
Closed -$621K – 5445
2024
Q3 		$640K Buy
+59,772
New +$651K ﹤0.01% 2817
2023
Q2 		– Sell
-10,337
Closed -$123K – 4457
2023
Q1 		$113K Buy
+10,337
New +$127K ﹤0.01% 3635
2021
Q3 		– Sell
-18,975
Closed -$189K – 6463
2021
Q2 		$189K Sell
18,975
-24,034
-56% -$235K ﹤0.01% 5054
2021
Q1 		$404K Buy
43,009
+31,380
+270% +$486K ﹤0.01% 4034
2020
Q4 		$267K Buy
11,629
+222
+2% +$4.54K ﹤0.01% 3891
2020
Q3 		$161K Buy
11,407
+1,194
+12% +$17.4K ﹤0.01% 3963
2020
Q2 		$159K Sell
10,213
-233
-2% -$2.84K ﹤0.01% 3956
2020
Q1 		$101K Sell
10,446
-16,594
-61% -$158K ﹤0.01% 4013
2019
Q4 		$258K Buy
+27,040
New +$248K ﹤0.01% 3775
2019
Q3 		– Sell
-14,937
Closed -$162K – 4546
2019
Q2 		$186K Sell
14,937
-12,351
-45% -$157K ﹤0.01% 3756
2019
Q1 		$371K Buy
27,288
+641
+2% +$7.83K ﹤0.01% 3116
2018
Q4 		$246K Sell
26,647
-1,834
-6% -$20.2K ﹤0.01% 3437
2018
Q3 		$344K Sell
28,481
-12,694
-31% -$178K ﹤0.01% 3570
2018
Q2 		$619K Hold
41,175
– – ﹤0.01% 2800
2018
Q1 		$619K Buy
41,175
+19,871
+93% +$302K ﹤0.01% 2800
2017
Q4 		$307K Buy
21,304
+2,741
+15% +$37.7K ﹤0.01% 3592
2017
Q3 		$280K Buy
+18,563
New +$246K ﹤0.01% 3353
2017
Q1 		– Sell
-22,981
Closed -$145K – 4516
2016
Q4 		$114K Buy
+22,981
New +$159K ﹤0.01% 4009

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wolverine Trading's FOLD Position: Q3 2025 in Review

Wolverine Trading reduced its Amicus Therapeutics (FOLD) stake by 57% in Q3 2025, selling an estimated $107K and leaving 11,399 shares worth $90.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5231.

Wolverine Trading first reported a position in FOLD in Q4 2016 and has held it in 21 quarters since. The position peaked at $640K in Q3 2024. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • Wolverine Trading held 11,399 shares of Amicus Therapeutics worth $90.5K as of Q3 2025.
  • Wolverine Trading sold 15,039 Amicus Therapeutics shares in Q3 2025, an estimated $107K.
  • Amicus Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5231 holding.
  • Wolverine Trading first reported a position in Amicus Therapeutics in Q4 2016 and has held it in 21 quarters since.
  • Wolverine Trading's Amicus Therapeutics position peaked at $640K in Q3 2024.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.